Drug intelligence / Profile preview

panlongqi

Development stage
Phase 3
Lead developer
Panlong Pharmaceutical
Administration
Oral
01

Overview

Panlongqi is a traditional Chinese medicine (TCM) compound prescription used for the treatment of osteoarthritis, rheumatoid arthritis, and bone injuries. It is most commonly available as the Panlongqi Tablet (Panlongqi Pian), which is manufactured by Shaanxi Panlong Pharmaceutical Group. The formula consists of 29 medicinal herbs, including *Bergenia purpurascens* (from which it derives its name), *Panax notoginseng*, *Carthamus tinctorius*, and *Angelica sinensis*. Its pharmacological actions include anti-inflammatory, analgesic, and microcirculation-improving effects, achieved through the regulation of inflammatory mediators such as TNF-α and IL-1β. It is clinically indicated for relieving joint pain, swelling, and functional limitations in patients with knee osteoarthritis. A Phase 3 clinical trial sponsored by Guang'anmen Hospital has investigated its efficacy and safety in this population.

Brand names
Panlongqi TabletPanlongqi Pian
Other names
Panlongqi
02

Targets

IL1B (Interleukin-1 beta)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on panlongqi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on panlongqi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call